[Precancerous lesions and IBD - pathological aspects]. (Q53367381)

13 May 2018

review article

1 reference

title

[Precancerous lesions and IBD - pathological aspects]. (English)

1 reference

13 May 2018

author name string

Jean-François Flejou

series ordinal

1

1 reference

13 May 2018

language of work or name

French

0 references

publication date

1 May 2004

1 reference

13 May 2018

Gastroenterologie Clinique et Biologique

published in

1 reference

13 May 2018

volume

28

1 reference

13 May 2018

issue

5 Suppl

1 reference

13 May 2018

page(s)

D140-8

1 reference

13 May 2018

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Management of dysplasia in ulcerative colitis: is prophylactic colectomy the preferred strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Rectal biopsy as an aid to cancer control in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Observer variation in the assessment of dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Inflammatory bowel disease and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Digital slide and virtual microscopy based routine and telepathology evaluation of routine gastrointestinal biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

The Vienna classification of gastrointestinal epithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

The color of dysplasia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Villous dysplasia. An ominous histologic sign in colitic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Diagnostic Problems and Advances in Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

The fate of low grade dysplasia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Screening and surveillance colonoscopy in chronic Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Lower gastrointestinal malignancy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Colorectal neoplasia in ulcerative colitis-recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Colorectal cancer in inflammatory bowel disease: molecular and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2804%2994998-6

7 January 2021

10.1016/S0399-8320(04)94998-6

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018